Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 832

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 832
---
 Company Stockholders; provided, however, that if the Merger Agreement is not terminated in accordance with its terms and the Merger and the Financing are consummated, the Board may not abandon the filing of the Series A Certificate of Designations; and be it further

RESOLVED , that upon the occurrence of certain events set forth in the Securities Purchase Agreement, the Series A Preferred Shares may be converted into shares of Company Common Stock as set forth therein; and be it further

#### Financing
RESOLVED , that the Financing be, and hereby is approved in all respects; and be it further

RESOLVED , that the forms, terms and provisions of the Financing Documents, and the transactions contemplated thereby, be and they hereby are authorized, adopted and approved in all respects; and be it further

RESOLVED , that the Authorized Officer be, and he acting singly hereby is, authorized and directed, for and on behalf of the Company, to execute and deliver the Financing Documents, together with such modifications, amendments or changes therein as the Authorized Officer executing the same may approve, such approval and the approval thereof by the Board to be conclusively established by such execution and delivery; and be it further

#### Registration Statements
RESOLVED , that the Authorized Officer, with the assistance of the Company’s accountants and counsel, be, and he hereby is, authorized to prepare, execute and file, or cause to be executed, delivered and filed, with the SEC on behalf of the Company, the Registration Statements and any prospectuses, exhibits, amendments and supplements relating thereto (including any post-effective amendments and any other registration statement required to be filed in accordance with the Registration Rights Agreement), for the registration of (i) the shares of Company Common Stock issuable upon the conversion of the Series A Preferred Shares to be paid by the Company in the Merger and (ii) the shares of Company Common Stock issuable upon conversion of the Series A Preferred Shares under the Securities

<div align='center'>E-4</div>

#### TABLE OF CONTENTS
Act of 1933, as amended (the “

#### Securities Act
”), in each case subject to all applicable laws, rules and regulations of the SEC and any SEC comments, including without limitation, all reports, statements, documents and information required to be filed by the Company pursuant to the Securities Exchange Act of 1934, as amended (the “

#### Exchange Act
”), the Securities Act or any other applicable laws, rules and regulations (including those of